Zeng Beilei, Huang Yinyin, Zhou Yuan, Li Ye, Huang Panwang, Xu Zhuangjian, Ma Yaping
Department of Pediatrics, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.
Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Front Pediatr. 2025 Aug 21;13:1629423. doi: 10.3389/fped.2025.1629423. eCollection 2025.
Body mass index (BMI) may influence peak luteinizing hormone (PLH) levels during gonadotropin releasing hormone (GnRH) or GnRH analogues stimulation testing. BMI effects should be considered when interpreting test results for pubertal disorders in girls with overweight/obesity, but few studies have excluded it.
This was a hospital data-based retrospective study. Girls with puberty disorders who had been followed up for six months to two years were enrolled in the study. They were divided into the overweight/obesity group and the normal BMI group and all underwent triptorelin stimulation test. Blood samples were collected at 0 min before and 20, 40, and 60 min after the test. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) serum concentrations were quantified by immunochemiluminometric assay.
A total of 422 girls who underwent 454 triptorelin stimulation tests were included in this study. Among 148 tests performed on 142 overweight/obesity girls, 110 tests were hypothalamic-pituitary-gonadal axis (HPGA) activated and 38 tests were HPGA non-activated. Among 306 tests performed on 284 girls with normal BMI, 214 tests were HPGA activated and 92 tests were non-activated. LH, FSH, and estradiol levels in girls whose HPGA activated were significantly higher than those non-activated. The area under the curves of LH20 min, LH40 min, LH60 min and PLH after triptorelin stimulation tests in girls with overweight/obesity for diagnosing HPGA activation were 0.996, 0.980, 0.990 and 0.994, respectively. There was no statistical significance in the area under the curves between LH20 min, LH40 min, LH60 min and PLH. When LH20 min, LH40 min, LH60 min and PLH were ≥3.26 IU/L, ≥4.09 IU/L, ≥4.27 IU/L and ≥4.51 IU/L, the sensitivity for diagnosing HPGA activation in girls with overweight/obesity were 99.03%, 95.45%, 98.18% and 97.27%, and the corresponding specificity were 94.59%, 97.37%, 100.00%, and 100.00%, respectively. The cut-off value of serum LH60 min after the triptorelin stimulation test for diagnosing HPGA activation in precocious pubertal girls with overweight/obesity was 4.45 IU/L, and in pubertal girls with overweight/obesity was 4.20 IU/L.
LH measurements obtained at 20, 40, or 60 min post-triptorelin stimulation can diagnose HPGA activation in girls with high BMI.
体重指数(BMI)可能会影响促性腺激素释放激素(GnRH)或GnRH类似物刺激试验期间的促黄体生成素峰值(PLH)水平。在解释超重/肥胖女孩青春期疾病的检测结果时,应考虑BMI的影响,但很少有研究将其排除。
这是一项基于医院数据的回顾性研究。纳入了随访6个月至2年的青春期疾病女孩。她们被分为超重/肥胖组和正常BMI组,均接受曲普瑞林刺激试验。在试验前0分钟以及试验后20、40和60分钟采集血样。通过免疫化学发光法测定促黄体生成素(LH)和促卵泡生成素(FSH)的血清浓度。
本研究共纳入422名接受454次曲普瑞林刺激试验的女孩。在对142名超重/肥胖女孩进行的148次试验中,110次试验下丘脑-垂体-性腺轴(HPGA)激活,38次试验HPGA未激活。在对284名正常BMI女孩进行的306次试验中,214次试验HPGA激活,92次试验未激活。HPGA激活女孩的LH、FSH和雌二醇水平显著高于未激活女孩。超重/肥胖女孩曲普瑞林刺激试验后LH20分钟、LH40分钟、LH60分钟和PLH用于诊断HPGA激活的曲线下面积分别为0.996、0.980、0.990和0.994。LH20分钟、LH40分钟、LH60分钟和PLH的曲线下面积之间无统计学意义。当LH20分钟、LH40分钟、LH60分钟和PLH分别≥3.26IU/L、≥4.09IU/L、≥4.27IU/L和≥4.51IU/L时,超重/肥胖女孩诊断HPGA激活的敏感性分别为99.03%、95.45%、98.18%和97.27%,相应的特异性分别为94.59%、97.37%、100.00%和100.00%。曲普瑞林刺激试验后血清LH60分钟用于诊断超重/肥胖性性早熟女孩HPGA激活的截断值为4.45IU/L,超重/肥胖青春期女孩为4.20IU/L。
曲普瑞林刺激后20、40或60分钟测得的LH值可诊断高BMI女孩的HPGA激活。